• IBC 33 | Seoul (Korea), Jul 2026 [Contributed]
  "A two-step causal inference approach for survival outcomes under time-varying latent confounding"

• EEC Network Meeting 23 | Jan 2026

"INDIvidualized loCAl Therapy for Ewing Sarcoma (INDICATES): a new clinical prediction tool"

• EEC Network Meeting 22 | London (UK), Jul 2025
  “Emulating a target trial to evaluate dose modifications and delays in VDC/IE therapy: Insights from Euro-Ewing 2012"

• General Mathematics Colloquium Leiden University | Leiden (NL), May 2025
  “Causal effects of chemotherapy regimen dose intensity on survival outcome: a retrospective study in osteosarcoma"

• EEC Network Meeting 20 | London (UK), Jun 2024 

"INDICATES: INDIvidualized loCAl Therapy for Ewing Sarcoma"

• LDE Causal Inference & AI for Health Meeting | Leiden (NL), Oct 2023
  "Investigating positivity violations in marginal structural survival models: a study on estimator IPTW performance" 

• University of Palermo | Palermo (IT), Mar 2023
  “Causal effects of chemotherapy regimen intensity on survival outcome in osteosarcoma patients through Marginal Structural Cox Models"

• SIG-HDS Leiden University | Leiden (NL), Jan 2023
  “Causal effects of chemotherapy regimen intensity on survival outcome in osteosarcoma patients through Marginal Structural Cox Models"

• Princess Máxima Center for Pediatric Oncology | Utrecht (NL), Jan 2023
  “Causal effects of chemotherapy regimen intensity on survival outcome in osteosarcoma patients through Marginal Structural Cox Models"

• MI PhD Colloquium Leiden University | Leiden (NL), Jun 2022
  “My PhD journey & my research"

• SIG-HDS Leiden University | Leiden (NL), Dec 2021
  “Modelling longitudinal Latent Overall Toxicity (LOTox) profiles in osteosarcoma patients”

• EORTC | Bruxelles (BE), Nov 2021
  “Modelling longitudinal Latent Overall Toxicity (LOTox) profiles in osteosarcoma patients”

• Leiden University Medical Center MSTAT | Leiden (NL), Nov 2021
  “Modelling longitudinal Latent Overall Toxicity (LOTox) profiles in osteosarcoma patients”

• Leiden University Medical Center | Leiden (NL), Apr 2021
  “Modelling longitudinal latent toxicity profiles evolution in osteosarcoma patients”

• MI Stat Leiden University | Leiden (NL), Dec 2021
  “Modelling longitudinal latent toxicity profiles in osteosarcoma patients”

• MOX Politecnico di Milano | Milan (IT), Jun 2020
  “Including time-varying covariates in time-to-event framework with applications to heart failure and osteosarcoma”

• Leiden Academic Centre for Drug Research | Leiden (NL), May 2020
  “Including dynamic covariates in survival models via Functional Data Analysis”

• Princess Máxima Center for Pediatric Oncology | Utrecht (NL), May 2020
  “Including dynamic covariates in survival models via Functional Data Analysis”

• MI Stat Leiden University | Leiden (NL), Dec 2019
  “Including dynamic covariates in survival models via Functional Data Analysis”

• [Upcoming] IBC 33 | Seoul (Korea), Jul 2026
  "A two-step causal inference approach for survival outcomes under time-varying latent confounding"

• ISI WSC 2025 | The Hague (NL), Oct 2025
  "Impact of positivity violations on marginal structural survival models: insights from a simulation study"

• SAfJR 2025 | Bonn (Germany), Mar 2025
  "Discrimination performance in illness-death models with interval-censored disease data"

• IBC 32 | Atlanta (USA), Dec 2024
  "Effect of positivity violations in marginal structural survival models: a simulation study on IPTW estimator performance"

• SAfJR 2023 | Ulm (DE), Sep 2023
  "Investigating positivity violations in marginal structural survival models: a simulation study"

• ISCB 44 | Milan (IT), Aug 2023
  "Investigating positivity violations in marginal structural survival models: a study on estimator performance" 

• IBC 31 | Riga (LV), Sep 2022
  “Causal effects of chemotherapy regimen intensity on survival outcome through Marginal Structural Models”

• SISMEC XI | Bari (IT), Sep 2021
  “Functional modelling of recurrent drug purchases and re-hospitalizations on survival in Heart Failure patients: a real-world case study"

• ISCB 42 | Lyon (FR), Sep 2021
  “Modelling the effect of longitudinal latent toxicity profiles on survival: an application to osteosarcoma”

• SIS 50 | Pisa (IT), Jun 2021
  “Modelling longitudinal latent toxicity profiles evolution in osteosarcoma patients”

• ISCB 41 | Krakow (PL), Aug 2020
  “Including dynamic covariates in survival models via Functional Data Analysis: an application to osteosarcoma”

• SISMEC X | Rome (IT), Sep 2019
  “Impact of time-dependent medication adherence on Heart Failure patients using a Joint Modelling framework”

• SIS 2019 | Milan (IT), Jun 2019
  “Joint Models: a smart way to include functional data in healthcare analytics”

• SISMEC 2018 | Rome (IT), Nov 2018
  “Target dosages and adherence to PolyPharmacy therapy: a case study based on a regional real-world HF community”

• ISCB 45 | Thessaloniki (EL), Jul 2024
  “Cluster-based recurrent marked point process approach for longitudinal volume-outcome studies"

• ISCB 43 | Newcastle Upon Tyne (UK), Aug 2022
  “Causal effects of chemotherapy dose intensity on survival outcome through Marginal Structural Models"

• ISCB 40 | Leuven (BE), Jul 2019
  “Investigating the role of Proteinuria in Renal Disease: a real-world clinical case study”

• SIS 49 | Palermo (IT), Jun 2018
  "Investigating the effect of drugs consumption on survival outcome of Heart Failure patients using joint models: a case study based on regional administrative data"